C’est avec un grand plaisir que nous avons participé à l’étape locale du “Big Tour” de BPI France. La rencontre s’est déroulé à Tourcoing. Cette initiative est destinée à mettre en valeur les entrepreneurs et entrepreneuses de la région Hauts-de-france. Notre CEO, Nathalie Maubon, a été interviewé pour présenter les Read more…
We are very please to annonce our selection in the “CO-INNO INTERNATIONAL” program. Jointly organised by BPI France and Hello Tomorrow, the CO-INNO program accelerates and supports the most cutting-edge French startups from the discovery of the Singaporean ecosystem to the establishment of technological partnerships, funding and even their settlement Read more…
After several awards and labels in the field of deeptech (Invest Horizon, Hello Tomorrow), we are happy to enter the deeptech community of Bpifrance (Banque Publique d’Investissement France). This community (on the platform lesdeeptech.fr in french) is a “link generator” between many stakeholders. First, it allows deeptech companies to share Read more…
During the last BIO Asia-Taiwan event HCS Pharma was awarded by the National Health Research Institute (NHRI) as a key company (關鍵新創) in the “Partnering and Medical Innovation” category (攜手同行暨創醫獎) for the BIOMIMESYS® technology. BIOMIMESYS® was recognized as a groundbreaking technology, allowing to reproduce any type of healthy or cancerous Read more…
Want to try 3D cell culture in your lab? Why not testing BIOMIMESYS®, our 3D cell culture system made in France? Please feel free to contact us at hello@biomimesys.com (or with this form) for any question… We will answer in french, or in english 🙂
Since the beginning of this year we have created four webinars to present our BIOMIMESYS® technology and practical uses. We have chosen to focus on the scientific side of our innovation by presenting results in drug discovery or dermocosmetology domains. Theses four webinars are available on our support page (with many Read more…
Nous sommes heureux de vous annoncer que le Ministère de l’Enseignement Supérieur et de la Recherche a accordé à HCS Pharma l’agrément au Crédit d’Impôt Recherche (CIR) jusqu’en 2023, en regard de nos activités de R&D. For non-french readers, the CIR (Research Tax Credit) concept is explain here. Our customers can Read more…
We are really proud to work on a real partnership with the team of Tokyo Future Style (TFS) Taïwan for almost a year now. Joseph Chou, member of our business advisory board and Pr John Lo, member of our scientific advisory board, have fully understood the value of BIOMIMESYS® our Read more…
With more than 25 countries represented, NutrEvent is THE place to be for business and innovation in Food, Nutrition and Health. It will take place next week in Rennes congress centre (Couvent des Jacobins), on the 22nd and 22rd of October. Our stand will be on Eurasanté Pavilion (Level 1 Read more…
Our CEO, Nathalie is the Chairwoman of the session “ Next Generation High-Content Bioimaging – Phenotypic Discovery” (Track 3 – session 2) at next SLAS Barcelona event. This event will bring together more than 1,000 scientists and technologists from around the world. The theme for the 2019 Europe Conference is Read more…
Every year, the CES (Consumer Electronics Show) in Las Vegas is the major meeting for technological innovations for consumer market. This year, many companies (more than 600) presented products and services in the healthcare domain (including medtech and wellness). It represents a 25% increase compared to 2018. Why is this Read more…
After having been eclipsed by Target-Based Screening, Phenotypic Screening is finally shining again
The pharmaceutical industry is in upheaval. Since 20 years, inefficiency of pharmaceutical industry to turn its discoveries into new drugs force them to change their model.
We will be present in the “innovation zone” during the Drug discovery 2015 in Telford the 2nd and 3rd of September in Telford.